Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D C, Nanho"'
Autor:
K. G. Koffi, D. C. Nanho, E. N'dathz, P. Kouehion, R. Dissieka, A. Attia, K. Mozard, A. Tolo, K. Boidy, N. Meité, R. Ayemou, M. Sekongo, N. Tea, I. Sanogo
Publikováno v:
Advances in Hematology, Vol 2010 (2010)
Imatinib mesylate, showed encouraging activity in chronic myelogenous leukemia. However, there are few data regarding his efficacy and response monitoring in Sub-Saharan African patients. Our objective was to assess response to imatinib mesylate (Gli
Externí odkaz:
https://doaj.org/article/af93ef80f2714b4e88a219e19fbff11c
Autor:
Amadou Sangaré, Emeraude N’dathz, Mori Meité, Aissata Tolo, Romeo Ayemou, Boidy Kouakou, Mamadou Y. Sekongo, Paul Kouéhion, Ibrahima Sanogo, D C Nanho, Mathias Yao Kouassi, Fatou Diago N’Diaye, N'Dogomo Meité, Norbert Dagnekpo Tea, Gustave Koffi
Publikováno v:
International Journal of Hematology. 91:838-843
African Burkitt lymphomas (BL) are highly aggressive lymphomas mainly affecting children and young adults in Africa. This lymphoma was marked by its high sensitivity to chemotherapy in comparison to Sporadic Burkitt lymphoma. In this study, we evalua
Autor:
Ibrahima Sanogo, Aissata Tolo-Diebkile, Kouassi Gustave Koffi, Romeo Ayemou, Emeraude N'dhatz, Yassongui Mamadou Sekongo, D C Nanho, Liliane Siransy-Bogui, N'Dogomon Méité, Boidy Kouakou, Duni Sawadogo
Publikováno v:
Cahiers de Santé. 20:63-67
Sickle cell disease is a genetic disease characterized by the synthesis of an abnormal haemoglobin called haemoglobin S. It is the most frequent of the hereditary anomalies of haemoglobin and occurs most commonly in individuals of African descent. Va
Autor:
N'Dogomo Meité, Paul Kouéhion, Ibrahima Sanogo, Kouassi Gustave Koffi, D C Nanho, Emeraude N’dathz, Aissata Tolo, Romeo Ayemou
Publikováno v:
Cahiers de Santé. 20:69-72
In this retrospective study, we analysed rare localisations of Burkitt lymphoma observed in the Haematology Department of the University Hospital of Yopougon Abidjan. Over a 10-year study period, we saw 106 patients with Burkitt lymphoma, 21 with unu
Autor:
Paul Kouéhion, Emeraude N’dathz, Aissata Tolo, Romeo Ayemou, Mamadou Y. Sekongo, K. Boidy, D C Nanho, Ibrahima Sanogo, N'Dogomo Meité, K. Mozard, Kouassi Gustave Koffi, A. K Attia, R. Dissieka, N. Tea
Publikováno v:
Advances in Hematology, Vol 2010 (2010)
Advances in Hematology
Advances in Hematology
Imatinib mesylate, showed encouraging activity in chronic myelogenous leukemia. However, there are few data regarding his efficacy and response monitoring in Sub-Saharan African patients. Our objective was to assess response to imatinib mesylate (Gli
Autor:
Ibrahima Sanogo, K G Koffi, Boidy Kouakou, Emeraude N’dathz, Romeo Ayemou, D. C. Nanho, Aissata Tolo, N'Dogomo Meité
Publikováno v:
Bulletin du Cancer. 96:901-906
Il s’agissait d’une etude retrospective a visee descriptive et analytique dont l’objectif etait de decrire les caracteristiques cliniques therapeutiques et evolutives des patients atteints de leucemie lymphoide chronique. Sur un total de 56 pat
Autor:
Paul Kouéhion, Romeo Ayemou, N'Dogomo Meité, Diebkilé Aïssata Tolo, Boidy Kouakou, Ismael Kamara, Mozart Konan, Duni Sawadogo, Yassongui Mamadou Sekongo, Ibrahima Sanogo, Kouassi Gustave Koffi, Alexis Dohoma Silue, D C Nanho, Emeraude N'dhatz
Publikováno v:
Advances in Hematology, Vol 2013 (2013)
Advances in Hematology
Advances in Hematology
We retrospectively studied 30 cases of multiple myeloma in patients under the age of 65, diagnosed from 1991 to 2005 in the clinical hematology department of the University Hospital of Yopougon that is a hospital incidence of 2.9 cases/year. The age
Publikováno v:
Bulletin du cancer. 96(9)
We reported in this retrospective study the clinical outcome of 56 chronic lymphoïd leukemia of black African in Ivory Coast and the predicting prognosis factors. The mean age was 62 years old with average of 38 to 84 years. According to Binet stagi
Autor:
D C, Nanho, F S, N'Diaye, A, Tolo, G S, Kouamenan, Y M, Sekongo, R, Ayemou, D, Meite, P, Kouehion, B, Kouakou, K G, Koffi, I, Sanogo, Amadou, Sangare
Publikováno v:
Le Mali medical. 23(3)
It acts of a retrospective study relating to 74 patients reached of chronic Leukaemia myeloid (LMC) over one 5 year period followed in the clinical service of hematology of the University Hospital of Yopougon (Abidjan, Ivory Coast). The splenomegaly
Publikováno v:
The hematology journal : the official journal of the European Haematology Association. 4(5)
T-lymphocyte subsets were studied in two patient groups: (1) 50 patients with homozygous sickle cell anaemia (SCA) (mean age 12 (range 3–32) years old) in good health at the time of the study who showed no infectious complication. (2) 50 patients (